U.S. Top Stock Picks from Analysts

Teva Pharmaceutical Industries

Market Cap: US$19.3b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Baxter International

Market Cap: US$14.4b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

QXO

Market Cap: US$13.8b

Distributes roofing, waterproofing, and other building products in the United States.

Moderna

Market Cap: US$12.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioMarin Pharmaceutical

Market Cap: US$11.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Aurora Innovation

Market Cap: US$10.7b

Operates as a self-driving technology company in the United States.

Primo Brands

Market Cap: US$10.4b

Operates as a branded beverage company in North America.

U-Haul Holding

Market Cap: US$10.4b

Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.

Liberty Broadband

Market Cap: US$9.2b

Engages in a range of communications businesses in the United States.

VinFast Auto

Market Cap: US$8.0b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Wix.com

Market Cap: US$7.8b

Operates a cloud-based web development platform for registered users and creators worldwide.

Legend Biotech

Market Cap: US$7.4b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Corcept Therapeutics

Market Cap: US$7.4b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Globus Medical

Market Cap: US$7.2b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Jazz Pharmaceuticals

Market Cap: US$7.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Repligen

Market Cap: US$6.9b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Revolution Medicines

Market Cap: US$6.9b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Caesars Entertainment

Market Cap: US$5.8b

Operates as a gaming and hospitality company.

Clearwater Analytics Holdings

Market Cap: US$5.6b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

Axsome Therapeutics

Market Cap: US$5.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Lantheus Holdings

Market Cap: US$5.0b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Pony AI

Market Cap: US$4.7b

Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China, the United States, and internationally.

Qfin Holdings

Market Cap: US$4.6b

Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China.

Alkermes

Market Cap: US$4.6b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

ACI Worldwide

Market Cap: US$4.6b

Develops, markets, installs, and supports software products and services for facilitating electronic payments in the United States and internationally.

BGC Group

Market Cap: US$4.6b

Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Vaxcyte

Market Cap: US$4.5b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Avidity Biosciences

Market Cap: US$4.4b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

ADMA Biologics

Market Cap: US$4.4b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Chagee Holdings

Market Cap: US$4.3b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

Cytokinetics

Market Cap: US$4.3b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

CBIZ

Market Cap: US$4.0b

Provides financial, insurance, and advisory services in the United States and Canada.

Freshworks

Market Cap: US$4.0b

A software development company, provides software-as-a-service products in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.

Globant

Market Cap: US$3.9b

Provides technology services worldwide.

Arcellx

Market Cap: US$3.9b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Inspire Medical Systems

Market Cap: US$3.9b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.